Private company
BIODELIVERY SCIENCES INTERNATIONAL INC
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
22.3%Operating margin3
50.9%Net margin3
6.5%Revenue growth, 20213
45.2%Return on equity3
$40.6MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Cost of revenue14¢$23.4M
- Other costs2¢$3.2M
- Income tax33¢$55.2M
- Profit51¢$84.9M
Out of $166.7M in revenue.3
Where each dollar of operating cash went, fiscal 2021
- Capital spending1¢$415.0K
- Share buybacks29¢$11.9M
- Kept or used elsewhere70¢$28.7M
Out of $41.0M of cash from operations.3
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $48.2M4 | $15.5M5 | $62.0M6 | $55.6M7 | $111.4M3 | $156.5M3 | $166.7M3 |
| Cost of revenue | $8.1M4 | $11.3M4 | $19.5M4 | $15.8M7 | $21.6M3 | $24.7M3 | $23.4M3 |
| Research and development | $20.6M4 | $18.9M5 | $13.0M6 | $4.9M7 | $07 | $07 | |
| Selling, general and admin | |||||||
| Operating income | -$35.2M4 | -$63.9M5 | -$29.4M6 | -$23.6M7 | $3.7M3 | $33.0M3 | $37.1M3 |
| Interest | $2.5M4 | $3.3M5 | $8.6M6 | $10.2M6 | $19.0M6 | ||
| Income tax | $04 | $04 | -$16.0M6 | $13.0K7 | $5.0K3 | $252.0K3 | -$55.2M3 |
| Net income | -$37.7M4 | -$67.1M5 | $5.3M6 | -$33.9M7 | -$15.3M3 | $25.7M3 | $84.9M3 |
| Earnings per share | -$0.724 | -$1.255 | $0.106 | -$0.737 | -$0.183 | $0.263 | $0.853 |
| Earnings per share (diluted) | -$0.724 | -$1.255 | $0.096 | -$0.737 | -$0.183 | $0.243 | $0.823 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $83.6M5 | $32.0M5 | $21.2M5 | $43.8M6 | $63.9M7 | $111.6M3 | $114.3M3 |
| Current assets | $92.5M8 | $42.5M4 | $39.7M5 | $66.0M6 | $117.8M7 | $182.4M3 | $202.1M3 |
| Total assets | $102.8M8 | $51.7M4 | $88.1M5 | $108.5M6 | $182.9M7 | $239.9M3 | $324.6M3 |
| Current liabilities | $28.1M8 | $19.3M4 | $26.1M5 | $21.5M7 | $54.0M7 | $53.0M3 | $82.4M3 |
| Total liabilities | $71.1M8 | $69.4M4 | $79.2M5 | $78.8M6 | $113.1M7 | $131.7M3 | $136.8M3 |
| Shareholders’ equity | $31.7M5 | -$17.7M6 | $8.9M7 | $29.7M3 | $69.8M3 | $108.2M3 | $187.8M3 |
| Shares outstanding | 52.7M shares8 | 54.1M shares4 | 55.9M shares5 | 70.8M shares6 | 96.2M shares7 | 101.4M shares3 | 98.9M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare BIODELIVERY SCIENCES INTERNATIONAL INC with another company
Former names
- MAS ACQUISITION XXIII CORPApr 13, 2000 to Apr 18, 20002
Recent filings
- Mar 22, 20228-K
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 22, 20224
- Mar 11, 20224
- Mar 9, 202210-K
- Feb 15, 20224
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8